期刊文献+

血清CA125与子宫内膜异位抗体测定对子宫内膜异位症中的诊断价值 被引量:3

下载PDF
导出
摘要 目的探讨联合检查在子宫内膜异位症中的临床价值。方法对为子宫内膜异位症患者30例、术前用放射免疫法测定CA125,并用酶免疫吸附法测定子宫内膜异位抗体水平。结果子宫内膜异位症组血清CA125水平为(79±40)U/ml,高于对照组(22±11)u/ml、子宫内膜异位症组子宫内膜异位抗体阳性率为55%,对照组为10%。单项测定CA125诊断子宫内膜异位症的敏感性为75%,特异性为83%;单项测定子宫内膜异位抗体诊断子宫内膜异位症的敏感性为55%,特异性为90%;如以两者均阳性为诊断标准,测敏感性为48%,特异性为100%;如以其中之一阳性为诊断标准,敏感性为82%,特异性为73%。结论测定CA125、子宫内膜异位抗体水平对子宫内膜异位症有较好的辅助诊断价值,联合测定更能提高诊断的正确性。
出处 《中国实用医药》 2010年第23期159-160,共2页 China Practical Medicine
  • 相关文献

参考文献3

二级参考文献9

  • 1王得玲 刘清华.子宫内膜异位症与血清CA125[J].实用妇科杂志,2000,16:56-57.
  • 2Barbieri RL. CA125 in patients with endometriosis [J]. Fertil Steril, 1986, 45 (6) : 767.
  • 3Krasnicki D. Sertml and peritoneal fluid CA125 concentration in women with en- dometriosis [J]. Ginekol Pol, 2001, 72 (12A): 1365.
  • 4Kajima. s, Takahashi K, Kitao M. Expression of CA125 in adenomyosis. Gynecol Obstet Invest, 1987, 23: 122- 126.
  • 5Masahashi T, Matsuzawa K, Ohsawa M, et al. Serum CAI25 levels in patients with en- dometriosis: change in CA125 levels during menstruation [J]. Obstet Gynecol, 1988, 72:328 - 333.
  • 6Halila H, Suikkari AM, Seep M. The effects of hysterectomy on serum CAI25 levels in patients with adenomyosis and uterine fibroids [J]. Hum Reprod, 1987, 2: 265-268.
  • 7Mathur S, Garza DE, Smith LF. Endome- trial autoantigens eliciting immunlglobulin (Ig) G, IgA, and IgM responses in endometriosis [J]. Fertil Steril, 1990, 54: 56 - 63.
  • 8McBean JII, Brumsted JR. In vitro CA125 secretion by endometrium from women with advanced endometriosis [ J ]. Fertil Steril, 1993, 59: 89-92.
  • 9陈慧琴,杜建明,于俊艳.抗子宫内膜抗体测定的临床应用评价[J].中级医刊,1998,33(3):31-32. 被引量:8

共引文献10

同被引文献47

  • 1路淑媛,周立娟,左娅.子宫内膜异位症治疗进展[J].中国现代药物应用,2009,3(6):126-127. 被引量:12
  • 2郎景和.子宫内膜异位症研究的任务与展望(之一)[J].中华妇产科杂志,2006,41(5):289-290. 被引量:124
  • 3张晶,张冰松,冯蕾,等.静脉超声造影妇科应用系列研究[C].中国超声医学工程学会第二届全国妇产及计划生育超声医学学术会议论文汇编,2008.
  • 4Sinaii N, Cleary SD, Ballweg ML, et al. High rates of autoimmnne and endocrine disorders,fibromyalgia, chronic fatigue syndrome and atopic diseases among women with endometriosis:a survey analysis [J]. Hum Reprod, 2002,17:2715-2724.
  • 5Mardon HH, Barlow D, Kennedy S. Delay in the diagnosis of en- dometriosis: a survey of women from the USA and the UK [J]. Hum Reprod, 1996,114:878-880.
  • 6Hummelshoj L, Prentice A, Groothuis P. Update on endometriosis[J]. Womens Health, 2006,2:53-56.
  • 7Bianchi M, Macaya R, Durruty G, et al. Correlation between CA125 marker with the presence and severity of pelvic endometriosis[J]. Rev MedChil, 2003, 131(4):367.
  • 8Chen Fang- Pin g, Song Yung- Kui, Li Ning, et al. The use of serum CA- 125 as a marker for endometriosis in patients with dysmenorrhea for monitoring therapy and forreeurrence of endometriosis [J]. Aeta Obst etrieiaet Gynecologica Seandinaviea,1998, 77:665-670.
  • 9Somigliana E, Vigano P, Candiani M, et al. Use of serum-soluble in- tercellular adhesion molecule-1 as a new marker of endometriosis [J]. Fertil Steril, 2002, 77:1028-1031.
  • 10T oki T, Kubot a J, Lu X, et al. Immunohist ochemical analysis of CA125, CA19- 9, and Ki- 67 in stage 3 or 4 endometriosis :positive correlation between serum CA125 level and endometriotic epithelial cell prolif- eration[J]. Acta Obstet Gynecol Scand,2000, 79:771-776.

引证文献3

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部